<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Hypertension — One‑Page Reference Algorithm (NICE CKS, May 2025)</title>
  <meta name="description" content="Clean, modern one‑page algorithm for the diagnosis and management of hypertension based on NICE CKS (May 2025)." />
  <style>
    :root{
      --bg: #0b0d10;
      --panel: #111418;
      --panel-2: #0e1115;
      --text: #e6e8eb;
      --muted: #a7b0b8;
      --brand: #5dd0ff;
      --brand-2: #6be28c;
      --accent: #ffd166;
      --danger: #ff6b6b;
      --ok: #90ee90;
      --shadow: 0 8px 24px rgba(0,0,0,.35);
      --radius: 16px;
    }

    /* Base */
    html,body{height:100%}
    body{
      margin:0; font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, "Helvetica Neue", Arial, "Apple Color Emoji", "Segoe UI Emoji";
      background: radial-gradient(1200px 700px at 10% -10%, #102020 0%, transparent 50%),
                  radial-gradient(1000px 600px at 110% 0%, #1a1622 0%, transparent 50%),
                  var(--bg);
      color:var(--text); line-height:1.45; letter-spacing:.2px;
    }

    .wrap{max-width:1100px; margin: 22px auto 64px; padding: 0 20px}

    /* Header */
    header{
      position: sticky; top: 0; z-index: 9; backdrop-filter: saturate(140%) blur(8px);
      background: linear-gradient(180deg, rgba(11,13,16,.9), rgba(11,13,16,.65));
      border-bottom: 1px solid #1c2128;
    }
    .header-inner{ max-width:1100px; margin:0 auto; padding:14px 20px; display:flex; align-items:center; gap:16px; }
    .logo{display:flex; align-items:center; gap:10px; text-decoration:none; color:var(--text)}
    .logo .mark{ width:28px; height:28px; display:grid; place-items:center; border-radius:8px; background: linear-gradient(135deg, var(--brand), var(--brand-2)); box-shadow: var(--shadow); }
    .logo b{font-weight:800; font-size: 16px; letter-spacing:.3px}
    .actions{ margin-left:auto; display:flex; gap:10px }
    .btn{
      appearance:none; border:none; border-radius: 999px; padding:10px 14px; font-weight:600;
      color:#0c1116; background: var(--brand);
      box-shadow: 0 4px 14px rgba(93,208,255,.35); cursor:pointer;
    }
    .btn.outline{ background: transparent; color: var(--text); border:1px solid #2a3038 }
    .btn:active{ transform: translateY(1px) }

    /* Title card */
    .hero{ margin-top:26px; background: linear-gradient(180deg, rgba(93,208,255,.12), rgba(107,226,140,.06)), var(--panel); border:1px solid #22272f; border-radius: var(--radius); padding: 18px 20px; box-shadow: var(--shadow); }
    .hero h1{ margin:0 0 6px; font-size: clamp(22px, 2.4vw, 30px); line-height:1.15; }
    .hero p{ margin:0; color:var(--muted) }
    .chips{ display:flex; gap:8px; flex-wrap: wrap; margin-top:10px }
    .chip{ font-size:12px; border-radius:999px; padding:6px 10px; background:#18212b; color:#cfe7ff; border:1px solid #253041 }

    /* Layout */
    .grid{ display:grid; gap:16px; grid-template-columns: repeat(12, 1fr); margin-top:20px }
    .col-6{ grid-column: span 6 }
    .col-12{ grid-column: span 12 }
    @media (max-width: 900px){ .col-6{ grid-column: span 12 } }

    /* Card */
    .card{ background: var(--panel-2); border: 1px solid #1f2430; border-radius: var(--radius); padding: 14px 14px; box-shadow: var(--shadow); }
    .card h2{ margin:2px 0 8px; font-size: 16.5px; letter-spacing:.2px }
    .card h3{ margin:12px 0 6px; font-size: 14px; color:#c9d6e1 }

    .list{ margin: 8px 0 0 0; padding-left: 18px }
    .list li{ margin: 6px 0 }

    /* Badges & kbd */
    .badge{ display:inline-flex; align-items:center; gap:6px; font-size: 12px; font-weight:700; padding:4px 8px; border-radius:999px; border:1px solid #2b3240; background:#151a21; color:#cfe7ff }
    .badge .dot{ width:8px; height:8px; border-radius:999px; background: var(--brand) }
    .badge.warn{ color:#ffe1c2; border-color:#44361e; background:#1b1510 }
    .badge.warn .dot{ background: var(--accent) }
    .badge.danger{ color:#ffd6d6; border-color:#4a2222; background:#1a0f11 }
    .badge.danger .dot{ background: var(--danger) }

    kbd{ font-family: ui-monospace, SFMono-Regular, Menlo, Monaco, Consolas, "Liberation Mono", "Courier New", monospace; background:#0f1620; border:1px solid #223048; padding: 2px 6px; border-radius:6px; font-size: 12px }

    /* Footer */
    footer{ margin: 18px 0 0; color: var(--muted); font-size: 12.5px }

    /* Accessibility helpers */
    a.skip{ position:absolute; left:-999px; top:auto; width:1px; height:1px; overflow:hidden }
    a.skip:focus{ position: static; width:auto; height:auto; padding:8px; border-radius:8px; background:#000; color:#fff }

    /* Print styles to fit ONE A4 page */
    @media print{
      @page{ size: A4; margin: 10mm }
      body{ background:#fff; color:#000 }
      header, .chips, .actions{ display:none !important }
      .wrap{ margin:0; padding:0 }
      .hero{ background:#fff; border:none; box-shadow:none; padding:0 0 6px 0 }
      .grid{ gap:10px; grid-template-columns: repeat(2, 1fr) }
      .card{ background:#fff; border:1px solid #ddd; box-shadow:none; padding:8px }
      .card h2{ font-size:12pt }
      .list li{ margin: 3px 0 }
      kbd{ border-color:#999 }
      footer{ font-size: 9pt; color:#333 }
    }
  </style>
</head>
<body>
  <a href="#content" class="skip">Skip to content</a>
  <header>
    <div class="header-inner">
      <a class="logo" href="#" aria-label="Hypertension quick reference home">
        <span class="mark" aria-hidden="true">
          <!-- Inline SVG mark -->
          <svg width="18" height="18" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true">
            <path d="M4 12h5l2-7 2 14 2-7h5" stroke="#0b0d10" stroke-width="2.2" stroke-linecap="round" stroke-linejoin="round"/>
          </svg>
        </span>
        <b>Hypertension — Quick Algorithm</b>
      </a>
      <div class="actions">
        <button class="btn outline" onclick="toggleDensity()" title="Toggle compact mode">Compact</button>
        <button class="btn" onclick="window.print()" title="Print or save as PDF">Print</button>
      </div>
    </div>
  </header>

  <main id="content" class="wrap" role="main">
    <section class="hero" aria-labelledby="title">
      <h1 id="title">One‑Page Reference Algorithm</h1>
      <p>Based on NICE CKS: <strong>Hypertension</strong> (last revised <strong>May 2025</strong>). Designed for rapid decision‑making at point of care.</p>
      <div class="chips" aria-hidden="true">
        <span class="chip">Adults ≥18 years</span>
        <span class="chip">Primary care</span>
        <span class="chip">UK practice</span>
        <span class="chip">Print‑friendly</span>
      </div>
    </section>

    <section class="grid" aria-label="Algorithm body">
      <!-- Left column -->
      <article class="card col-6" aria-labelledby="diagnosis">
        <h2 id="diagnosis">1) Confirm Diagnosis <span class="badge"><span class="dot"></span> Key thresholds</span></h2>
        <ul class="list">
          <li>Clinic <strong>≥140/90</strong> → repeat ×2; record lower of last two.</li>
          <li>Confirm with <strong>ABPM/HBPM</strong> average <strong>≥135/85</strong>.</li>
          <li><strong>Stages (clinic / ABPM–HBPM)</strong>:
            <ul class="list">
              <li>Stage 1: <kbd>140/90–159/99</kbd> / <kbd>135/85–149/94</kbd></li>
              <li>Stage 2: <kbd>≥160/100</kbd> / <kbd>≥150/95</kbd></li>
              <li>Severe: <kbd>≥180/120</kbd></li>
            </ul>
          </li>
          <li>White‑coat: clinic exceeds ABPM/HBPM by <strong>>20/10</strong>. Masked: normal clinic but raised out‑of‑clinic.</li>
          <li>Consider <strong>secondary HTN</strong> if &lt;40 y, resistant, accelerated, or atypical history/exam.</li>
        </ul>
        <h3><span class="badge danger"><span class="dot"></span> Same‑day specialist</span></h3>
        <ul class="list">
          <li>BP <strong>≥180/120</strong> with <em>retinal haemorrhage/papilloedema</em> or <em>life‑threatening symptoms</em> (new confusion, chest pain, heart failure, AKI).</li>
          <li>Suspected <strong>phaeochromocytoma</strong> (labile/postural BP, headache, palpitations, pallor, diaphoresis, abdo pain).</li>
        </ul>
      </article>

      <article class="card col-6" aria-labelledby="investigations">
        <h2 id="investigations">2) Baseline Investigations</h2>
        <ul class="list">
          <li>Target organ damage screen: urine <abbr title="albumin:creatinine ratio">ACR</abbr>, haematuria; fundoscopy; 12‑lead ECG.</li>
          <li>Bloods: <strong>HbA1c</strong>, electrolytes, creatinine, <strong>eGFR</strong>, lipids (total &amp; HDL).</li>
          <li><strong>QRISK</strong> 10‑yr CVD risk (use clinic BP).</li>
          <li>Specialist tests if signs of secondary causes or organ damage.</li>
        </ul>
        <h3>Monitoring Considerations</h3>
        <ul class="list">
          <li>Postural symptoms/diabetes/≥80 y: measure <strong>standing</strong> and seated BP; if standing drop <strong>≥20 mmHg</strong>, base target on standing and review therapy.</li>
          <li>For self‑monitoring: train on HBPM; use average of waking‑hours readings.</li>
        </ul>
      </article>

      <article class="card col-6" aria-labelledby="lifestyle">
        <h2 id="lifestyle">3) Lifestyle (all patients)</h2>
        <ul class="list">
          <li>Weight loss, regular exercise; heart‑healthy diet.</li>
          <li>Salt reduction; avoid KCl substitutes in older adults, CKD, diabetes, or on <abbr title="angiotensin‑converting enzyme inhibitors">ACEi</abbr>/<abbr title="angiotensin II receptor blockers">ARB</abbr>.</li>
          <li>Limit alcohol; stop smoking; moderate caffeine.</li>
          <li>Provide patient information and local support; annual CVD risk review.</li>
        </ul>
      </article>

      <article class="card col-6" aria-labelledby="thresholds">
        <h2 id="thresholds">4) When to Start Drug Treatment</h2>
        <ul class="list">
          <li><strong>Stage 2</strong>: offer drug therapy <em>regardless of age</em>.</li>
          <li><strong>Stage 1</strong>: if &lt;80 y with TOD/CVD/renal disease/diabetes or <strong>QRISK ≥10%</strong>.</li>
          <li>Consider if &lt;60 y even with QRISK &lt;10% (lifetime risk).</li>
          <li>≥80 y: treat if clinic <strong>≥150/90</strong>.</li>
          <li>Use clinical judgement in frailty/multimorbidity.</li>
        </ul>
      </article>

      <article class="card col-12" aria-labelledby="drugs">
        <h2 id="drugs">5) Drug Algorithm</h2>
        <h3>General</h3>
        <ul class="list">
          <li>Titrate to optimal/tolerated dose at each step; combinations are often required.</li>
          <li>Isolated systolic (SBP ≥160): treat as per combined HTN.</li>
          <li><strong>Do not combine ACEi + ARB.</strong></li>
          <li>Pregnancy/planning/breastfeeding: avoid ACEi/ARB unless essential—discuss risks.</li>
        </ul>
        <div class="grid" style="margin-top:10px">
          <div class="col-6">
            <h3>Step 1</h3>
            <ul class="list">
              <li><strong>&lt;55 y (non‑Black)</strong>: ACEi or ARB.</li>
              <li><strong>≥55 y</strong> or <strong>Black African/Caribbean (any age)</strong>: CCB.</li>
              <li><strong>T2DM (any age)</strong>: ACEi/ARB (prefer <strong>ARB</strong> if Black African/Caribbean).</li>
              <li>CCB intolerance or heart failure → thiazide‑<em>like</em> diuretic (e.g., indapamide).</li>
            </ul>
          </div>
          <div class="col-6">
            <h3>Step 2</h3>
            <ul class="list">
              <li>If on ACEi/ARB → add <strong>CCB</strong> or thiazide‑like diuretic.</li>
              <li>If on CCB → add <strong>ACEi/ARB</strong> or thiazide‑like diuretic.</li>
            </ul>
          </div>
          <div class="col-6">
            <h3>Step 3</h3>
            <ul class="list">
              <li>Triple therapy: <strong>ACEi/ARB + CCB + thiazide‑like</strong>.</li>
            </ul>
          </div>
          <div class="col-6">
            <h3>Step 4 — Resistant HTN</h3>
            <ul class="list">
              <li>Confirm with ABPM/HBPM; assess for postural drop; support adherence.</li>
              <li><strong>K⁺ ≤4.5</strong>: add low‑dose <strong>spironolactone</strong> (check eGFR).</li>
              <li><strong>K⁺ &gt;4.5</strong> or unsuitable: add <strong>α‑blocker</strong> or <strong>β‑blocker</strong>.</li>
              <li>Uncontrolled on 4 drugs → seek specialist advice.</li>
            </ul>
          </div>
        </div>
      </article>

      <article class="card col-6" aria-labelledby="targets">
        <h2 id="targets">6) Treatment Targets</h2>
        <ul class="list">
          <li><strong>&lt;80 y</strong>: clinic <strong>&lt;140/90</strong> (<abbr title="ambulatory/home BP">ABPM/HBPM</abbr> <strong>&lt;135/85</strong>).</li>
          <li><strong>≥80 y</strong>: clinic <strong>&lt;150/90</strong> (ABPM/HBPM <strong>&lt;145/85</strong>).</li>
          <li>Frailty/multimorbidity: individualise targets.</li>
        </ul>
      </article>

      <article class="card col-6" aria-labelledby="followup">
        <h2 id="followup">7) Follow‑up &amp; Safety</h2>
        <ul class="list">
          <li>Check <strong>U&amp;Es/eGFR</strong> ~1 month after starting ACEi/ARB/diuretic; repeat as needed.</li>
          <li>Review adherence and adverse effects at each step.</li>
          <li>Annual review: BP, risk factors, target organ damage, patient education.</li>
        </ul>
        <h3 class="sr-only">Notes</h3>
        <ul class="list">
          <li>Prefer <strong>thiazide‑like</strong> over conventional thiazides when initiating.</li>
          <li>Use generics where appropriate.</li>
        </ul>
      </article>

      <article class="card col-12" aria-labelledby="notes">
        <h2 id="notes">Scope &amp; Exclusions</h2>
        <ul class="list">
          <li>Adults ≥18 years. Primary HTN management in primary care.</li>
          <li>Not covered here: CKD‑specific targets, type 1 diabetes, pregnancy, children, confirmed secondary HTN (see relevant guidance).</li>
        </ul>
      </article>
    </section>

    <footer>
      <p><strong>Source:</strong> NICE Clinical Knowledge Summaries — <em>Hypertension</em>, last revised May 2025. This quick reference is for healthcare professionals and does not replace clinical judgement. © for layout/design this copy. Drug examples are indicative, not exhaustive.</p>
    </footer>
  </main>

  <script>
    // Compact mode for tighter spacing if you need to squeeze to a single sheet
    function toggleDensity(){
      document.documentElement.classList.toggle('compact');
    }
  </script>
  <style>
    /* Compact mode toggled by button for tighter clinic printouts */
    .compact .card{ padding:10px }
    .compact .card h2{ margin:0 0 6px }
    .compact .list li{ margin:4px 0 }
    .compact .hero{ padding:12px 14px }
  </style>
</body>
</html>
